GlassScriptPhysician profile
James M Lackey
NPI 1730255050
$330.19
in general payments reported to CMS, 2019-2025
11 companies · $81.74 in 2025
The $81.74 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $49.44 · 2020: $82.98 · 2021: $28.18 · 2022: $23.75 · 2024: $64.10 · 2025: $81.74.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $146.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $145.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $62.46 | 2025 | Spravato |
| Lilly USA, LLC | $50.19 | 2020-2021 | |
| Glaxosmithkline, LLC. | $48.33 | 2020-2021 | |
| Insulet Corporation | $30.63 | 2024 | Omnipod |
| Astrazeneca Pharmaceuticals LP | $30.61 | 2019-2025 | Airsupra |
| Abbvie INC. | $23.75 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $19.80 | 2019 | |
| Medtronic USA, INC. | $18.31 | 2019 | |
| Novo Nordisk INC | $17.24 | 2024 | |
| Siemens Medical Solutions USA, INC. | $16.23 | 2024 | Advia Chemistry Xpt System |
| Pfizer INC. | $12.64 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Lackey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.